Expectations trend
FY2028 · fiscal year ending 2028-03-31 · fmp
BENEFICIENT (BENF)
NASDAQFinancialsAsset ManagementSnapshot 2026-11-04
$0.69-10.58%
Close 2026-11-05 · 1-day change
NASDAQFinancialsAsset ManagementSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.01 → 0.01 EPS · FY ending Mar 31, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BENF yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Primary capital transactions reach $8.75 million in 2026-Q3 | Beneficient aims to grow capital transactions to $8.75 million in Q3 2026. | Intact | Primary capital transactions fall below $3 million in 2026-Q3 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-03-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making financial business rather than a proven durable compounder. Its one-to-three-month thesis state is watch, despite a recent shift to a mildly favorable signal.
The snapshot provides no valuation measures or direct evidence of what the market expects, so whether BENF is cheap or expensive versus peers cannot be assessed. The recent signal improved, but the weak financial performance and litigation concerns remain part of the current picture.
Near term, erratic earnings and the smaller-cap risk point to an elevated chance of missing next-quarter earnings. Ben Custody revenue declined in fiscal 2026, while a first collateral management engagement marks limited progress; the supplied evidence does not show measurable AI commercialization. The company has taken a legal step against purported HCLP debt, but the debt has not been eliminated in the supplied disclosures.
Over the next one to three years, the thesis hinges on resolving the HCLP debt and Heppner interests and turning new services into sustained revenue. Near term, Federal Reserve rate moves and earnings results from financial-sector bellwethers such as BLK, BX, and KKR could strengthen or weaken sector momentum. Progress on these factors would need to be weighed against BENF’s weak recent results and elevated earnings risk.
The one-to-three-year view remains uncertain: the signal has improved, but evidence of durable financial progress is limited and significant debt, legal, and earnings risks remain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in BENEFICIENT's published investment case. The stated target is No major disruptive leadership changes. |
| Under Pressure |
| Unexpected CEO or key officer departures causing instability |
Qualitative: Active litigation against former CEO Brad Heppner Company filed motion to intervene in litigation to invalidate credit agreement and equity interests held by former CEO Brad Heppner. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain positive net income of $19.9 million in 2026-Q3 | The company reported $19.9 million net income in Q3 2026. | Broken | Net income falls below zero in any quarter after 2026-Q3 | Net income: $-6.783M FY2027-Q1; GAAP. Published target: net income >= $19.9 million. The stored target says 2026-Q3; this source reports FY2027-Q1. Fiscal/calendar alignment needs review. Aug 14, 2026-6,783,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.56 → $0.01 · observed estimates
$0.00B → $0.05B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-14 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-15 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-16 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-17 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-18 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-19 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-20 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-21 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-22 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-23 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-24 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-25 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-26 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-27 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-28 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-29 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-30 | $0.56 | $868,000 | 1 / 1 |
| 2026-08-31 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-01 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-02 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-03 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-04 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-05 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-06 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-07 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-08 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-09 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-10 | $0.56 | $868,000 | 1 / 1 |
| 2026-09-11 | $0.56 | $48,590,000 | 1 / 1 |
| 2026-09-12 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-13 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-14 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-15 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-16 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-17 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-18 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-19 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-20 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-21 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-22 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-23 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-24 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-25 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-26 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-27 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-28 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-29 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-09-30 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-01 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-02 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-03 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-04 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-05 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-06 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-07 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-08 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-09 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-10 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-11 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-12 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-13 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-14 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-15 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-16 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-17 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-18 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-19 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-20 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-21 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-22 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-23 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-24 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-25 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-26 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-27 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-28 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-29 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-30 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-10-31 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-11-01 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-11-02 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-11-03 | $0.01 | $48,590,000 | 1 / 1 |
| 2026-11-04 | $0.01 | $48,590,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.